IHH Healthcare Berhad Promising secular growth despite near-term challenges
|
|
- Amelia Morris
- 5 years ago
- Views:
Transcription
1 28 April 2016 Corporate Update IHH Healthcare Berhad Promising secular growth despite near-term challenges Maintain NEUTRAL Unchanged Target Price (TP): RM7.10 INVESTMENT HIGHLIGHTS Singapore to continue as the main revenue contributor Turkey remains a strong home market North Asia is the way forward India as the next promising market Looking beyond 2020 Maintain NEUTRAL with unchanged TP of RM7.10 Singapore to continue as the main revenue contributor. As of FY15, Pantai Parkway Life Singapore (PPL Singapore) is both the main contributor to revenue and PATAMI of IHH. PPL Singapore contributes about 38% of the group s overall revenue and 51% of the group s total PATAMI. We are expecting PPL Singapore to continue being the main contributor for both revenue and PATAMI in the medium term with the gradual opening of new wards in Mount Elizabeth Novena. Additionally, the group is trying to leverage on Singapore s growing ageing population which is known to drive the increase in complex cases. We are expecting these cases which are high in revenue intensities to occur more in Singapore due to its demographic condition. Furthermore, Singapore also has supportive national insurance policies, i.e. Medisave, Medishield Life and Integrated Shield Plan (ISP), which allows the utilisation of a person s cumulative insurance premium to partly fund the treatments in private hospitals. Turkey remains a strong home market. Despite being affected by the weak Turkish Lira (TRY), Turkey remains a strong home market for IHH in our opinion. Both inpatient admissions and revenue intensities recorded in Turkey has been on an increasing trend for the past two years, albeit marginally. However, in FY15 Acibadem s new hospitals recorded a 91%yoy increase in revenue, the highest amongst IHH s home markets. Going forward, we think the contribution coming from Turkey s Acibadem will continue to increase due to: (i) openings of new hospitals, (ii) high number of local participation (Turkey has 80m population), (iii) its strategic location (in between the Asian and European continents), and (iv) other self-sustaining services that are beyond its hospitals and outpatient clinics such as: Acibadem Project Management, Acibadem Insurance, Acibadem Mobile, Acibadem University, A Plus and Acibadem Labmed. Refer to Chart 1. RETURN STATS Price (27 April 16) Target Price RM6.64 RM7.10 Expected Share Price Return +7.00% Expected Dividend Yield +0.80% Expected Total Return +7.8% STOCK INFO KLCI Bursa / Bloomberg Board / Sector Syariah Compliant / IHH MK Main / Trading Services YES Issued shares (mil) 8, Par Value (RM) 1.00 Market cap. (RM m) 54, Price over NA wk price Range RM5.32 RM6.75 Beta (against KLCI) mth Avg Daily Vol 7.26m 3-mth Avg Daily Value Major Shareholders (%) RM47.5m Khazanah Nasional Bhd Mitsui & Co Ltd EPF 8.84 MIDF RESEARCH is a unit of MIDF AMANAH INVESTMENT BANK Kindly refer to the last page of this publication for important disclosures
2 Chart 1: Acibadem s ecosystem Source: Company North Asia is the way forward. In early 2017, IHH will be opening its long-awaited Gleneagles Hong Kong (GHK). The hospital will be a 500-bedded medical facility in collaboration with the University of Hong Kong. The hospital will be offering packaged rate for 250 of its beds and normal rates for the remaining 250 beds. The reception towards the hospital has been positive as Hong Kong has been experiencing shortage of beds and GHK will be the first new hospital in Hong Kong after 30 years. In addition, GHK will also be offering financial counselling for its patients upon admission and the general pricing for its services is expected to be at 30-50% premium from its current pricing in Singapore. This is also due to the higher cost associated with operating in Hong Kong. Going forward, IHH is planning to expand its presence in North Asia by narrowing its strategy and targeting the four most populous regions in China. To date, IHH is operating a primary care network with 10 clinics in Shanghai and it has also recently announced a JV in Chengdu with Perennial International Health and Medical Hub Chengdu, for a 350- bedded hospital to be called ParkwayHealth Chengdu. The management is expecting the hospital to be completed end Meanwhile, the company continues to look for opportunities in other regions, i.e. northern and southern regions, to further strengthen their presence in North Asia and capitalize on China s affluent and high density population. Refer to Chart 2 below. Chart 2: IHH s North Asia strategy 2
3 India as the next promising market. The acquisition of Global and Continental Hospitals back in 2015 has opened an even bigger door for IHH into the world s second most populous country. Though prior to the two acquisitions, IHH has a 10.8% stake in Apollo Hospitals with an ongoing JV to build Gleneagles Khubchandani, these hospitals are and will be providing the general core health services. This is in contrast to Global and Continental Hospitals that are more skewed towards organ transplants and upper gastrointestinal cases respectively. Looking ahead, we are expecting IHH to most likely acquire more hospitals in India in order for it to strengthen its presence and complement its newly acquired hospitals. This is mainly due to the fact that the period it takes to build a hospital from scratch in India, takes longer than acquiring existing hospitals. In addition, we are also expecting IHH to bring its expertise in providing general core health services and synergies (in terms of procurement and financial management) to complement Global and Continental s specialties to create an all-round healthcare service operator. Leveraging on the large population and lack of quality private healthcare in the country, management is expecting a combined 10% revenue contribution from both North Asia and India in the medium term. Table 1: IHH s licensed bed pipelines 2016 Licensed bed pipeline (units) Gleneagles Medini 24 Mount Elizabeth Novena 30 Acibadem Sistina Skopje 81 Total onwards Gleneagles Hong Kong 500 Gleneagles Khubchandani India* 450 ParkwayHealth Chengdu 350 Acibadem Altunizade 325 Acibadem Maslak 200 Pantai Ayer Keroh 160 Continental Hospital India 100 Total 2,085 *Tentative Looking beyond The group has also started to look beyond 2020 with its focus turning to Indo-China countries that are expected to experience increase in wealth and healthcare awareness which we are expecting to drive the demand for private healthcare services in the region. As the Indo-China countries began to embark on improving the quality of their healthcare services, we opine that private healthcare providers such as IHH will tend to benefit from the region s long-term income growth potential by tapping into these markets as the countries experience gradual increase in middle class population. Furthermore, the steady increase in expatriates and foreign tourists stemming from gradual liberalisation of the economies and increased tourism interests will assist in driving the demand further for private healthcare services. Recall that IHH announced back in January its foray into Myanmar with an USD70m, 250-bed hospital to be called Parkway Yangon. IHH will have a 52% JV stake via Andaman Alliance Healthcare Limited in the hospital and it will be based on a build-operate-transfer model. The hospital will be located in downtown Yangon on a 4.3 acres plot of land leased for 50 years with an option of two 10-years extensions. The hospital is expected to open in
4 But challenges persist. Despite the positive long term outlook for IHH, we are still wary on the challenges that it currently faces in all the markets they are in. Malaysia for example, has been affected by the double whammy coming from the implementation of goods and services tax (GST) back in April 2015 and Ringgit s volatility which resulted in a prolonged soft consumer sentiment. As for Turkey, the continued weak performance of TRY and geo-political instability might limit Acibadem from realising its full revenue potential. Not forgetting the increasing costs across all markets which range from medical consumables, medicines, and cost of personnel and so on due to inflationary pressures. Earnings forecast. As we are adopting a cautiously optimistic view on the operating environment this year, we are making no changes to our earnings forecasts for FY16-17 at this juncture. Nonetheless, our forecasts represent a 11-13% increase in revenue and 21-23% increase in earnings for FY16-17 which is consistent with its: (i) double digit growth since IPO, (ii) expected continued challenging macroeconomic environment, and (iii) expected number of beds in the pipeline. The key risks to our earnings are: i) volatility in the currency market, ii) lower than expected inpatient admissions and revenue per patient, and iii) increasing cost of operations in its key home markets. Chart 3: IHH historical yearly revenue Chart 4: IHH s historical yearly core PATAMI CAGR: 14% Maintain NEUTRAL with an unchanged Target Price (TP) of RM7.10. We are reiterating our NEUTRAL recommendation on IHH with an unchanged DCF-based TP of RM7.10 per share (TG: 4.5%, WACC: 9.0%). We think that despite the resilient demand and growth for healthcare services in its three home markets, FY16 will remain a challenging year given the volatility in the currency market, increasing competition for healthcare personnel in its home markets and higher minimum wages in Turkey. We opine that the re-rating catalysts for the stock are: (i) faster gestation period for its newly opened hospitals, and (ii) higher contribution from North Asia and Indian hospitals. 4
5 Chart 5: IHH s quarterly inpatient admissions Chart 6: IHH s quarterly revenue per inpatient INVESTMENT STATISTICS FYE Dec (RM 'm) FY12 FY13 FY14 FY15 FY16F FY17F Revenue 6,962 6,756 7,344 8,431 9,398 10,664 EBITDA 1,561 1,767 1,914 2,077 2,359 3,033 Core PATAMI ,087 1,339 Basic EPS (sen) PATAMI growth (%) PER (x) Dividend per share (sen) Dividend yield (%) Source: Company, Forecasts by MIDFR DAILY PRICE CHART Noor Athila Mohd Razali noor.athila@midf.com.my
6 MIDF RESEARCH is part of MIDF Amanah Investment Bank Berhad ( X). (Bank Pelaburan) (A Participating Organisation of Bursa Malaysia Securities Berhad) DISCLOSURES AND DISCLAIMER This report has been prepared by MIDF AMANAH INVESTMENT BANK BERHAD (23878-X). It is for distribution only under such circumstances as may be permitted by applicable law. Readers should be fully aware that this report is for information purposes only. The opinions contained in this report are based on information obtained or derived from sources that we believe are reliable. MIDF AMANAH INVESTMENT BANK BERHAD makes no representation or warranty, expressed or implied, as to the accuracy, completeness or reliability of the information contained therein and it should not be relied upon as such. This report is not, and should not be construed as, an offer to buy or sell any securities or other financial instruments. The analysis contained herein is based on numerous assumptions. Different assumptions could result in materially different results. All opinions and estimates are subject to change without notice. The research analysts will initiate, update and cease coverage solely at the discretion of MIDF AMANAH INVESTMENT BANK BERHAD. The directors, employees and representatives of MIDF AMANAH INVESTMENT BANK BERHAD may have interest in any of the securities mentioned and may benefit from the information herein. Members of the MIDF Group and their affiliates may provide services to any company and affiliates of such companies whose securities are mentioned herein This document may not be reproduced, distributed or published in any form or for any purpose. MIDF AMANAH INVESTMENT BANK : GUIDE TO RECOMMENDATIONS STOCK RECOMMENDATIONS BUY TRADING BUY NEUTRAL Total return is expected to be >15% over the next 12 months. Stock price is expected to rise by >15% within 3-months after a Trading Buy rating has been assigned due to positive newsflow. Total return is expected to be between -15% and +15% over the next 12 months. SELL TRADING SELL Total return is expected to be <15% over the next 12 months. Stock price is expected to fall by >15% within 3-months after a Trading Sell rating has been assigned due to negative newsflow. SECTOR RECOMMENDATIONS POSITIVE NEUTRAL NEGATIVE The sector is expected to outperform the overall market over the next 12 months. The sector is to perform in line with the overall market over the next 12 months. The sector is expected to underperform the overall market over the next 12 months. 6
KPJ Healthcare Berhad Moving on cautiously into FY16
14 January 2016 Corporate Update KPJ Healthcare Berhad Moving on cautiously into FY16 INVESTMENT HIGHLIGHTS Cautious outlook for FY16 Expansion plan to resume Overseas operation to remain subdued in FY16
More informationKPJ Healthcare Berhad Higher operating expenses a drag on earnings
24 November 2017 3QFY17 Results Review KPJ Healthcare Berhad Higher operating expenses a drag on earnings INVESTMENT HIGHLIGHTS 3QFY17 earnings below expectations at RM30.6m Revenue boosted by organic
More informationUEM Edgenta Berhad Expanding IFM presence to Singapore and Taiwan
27 September 2016 Corporate Update UEM Edgenta Berhad Expanding IFM presence to Singapore and Taiwan INVESTMENT HIGHLIGHTS Proposed acquisition of AIFS Expanding IFM business to Singapore and Taiwan A
More informationSyarikat Takaful Malaysia Berhad Ending on a high note
25 January 2017 4QFY16 Results Review Syarikat Takaful Malaysia Berhad Ending on a high note Maintain BUY Unchanged Target Price (TP): RM4.84 INVESTMENT HIGHLIGHTS Syarikat Takaful Malaysia Bhd (STMB)
More informationUEM Edgenta Berhad New ventures to sustain growth
05 May 2016 Corporate Update UEM Edgenta Berhad New ventures to sustain growth INVESTMENT HIGHLIGHTS Post-M&A so far Sustaining the current business Plugging in the leakage Venturing into township management
More informationMalaysia Airports Holdings
02 May 2017 1QFY17 Results Review Malaysia Airports Holdings Promising start to the year INVESTMENT HIGHLIGHTS MAHB had a promising start to the year International traffic drove up PSC, retail and rental
More informationTenaga Nasional New policy underpins rising dividend potential
13 December 2016 Corporate Update Tenaga Nasional New policy underpins rising dividend potential Maintain BUY Unchanged (TP): RM16.80 Tenaga announced a new dividend policy of a 30%-50% earnings payout
More informationTelekom Malaysia Berhad Unifi customer base crossed one million
30 August 2017 2QFY17 Results Review Telekom Malaysia Berhad Unifi customer base crossed one million INVESTMENT HIGHLIGHTS 2Q17 normalised earnings grew by +24.2%yoy due to healthier normalised PATAMI
More informationKINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES
16 August 2018 2QFY18 Results Review Public Bank Berhad Higher than expected interim dividend Maintain BUY Unchanged Target Price (TP): RM27.30 INVESTMENT HIGHLIGHTS Earnings within expectations Net profit
More informationMalaysia Airports Holdings Berhad
11 August 017 Corporate Update Malaysia Airports Holdings Berhad International pax growing strong Maintain BUY Unchanged Target Price (TP): RM9.98 INVESTMENT HIGHLIGHTS Pax growth remains robust in July
More informationKINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES
28 November 2016 1QFY17 Results Review Sime Darby Berhad FFB production affected by El Nino INVESTMENT HIGHLIGHTS 1QFY17 core earnings below expectation Plantation division FFB volume is lower than expected
More informationMalaysia Airports Holdings Dampened by higher depreciation and amortisation
18 February 2016 4QFY15 Results Review Malaysia Airports Holdings Dampened by higher depreciation and amortisation Maintain NEUTRAL Unchanged Target Price (TP): RM6.35 INVESTMENT HIGHLIGHTS FY15 earnings
More informationINVESTMENT HIGHLIGHTS
28 August 2014 2QFY14 results review UMW Holdings Berhad Dragged by non-profitable legacy businesses INVESTMENT HIGHLIGHTS Poor set of 2Q14 results as core earnings declined -18% over sequential and on-year
More informationM&A Research. Result Review (1Q16) M&A Securities. IHH Healthcare Bhd. Integrating Newly Acquired Assets HOLD (TP: RM6.
M&A Research M&A Securities Result Review (1Q16) PP14767/09/2012(030761) Friday, May 27, 2016 IHH Healthcare Bhd HOLD (TP: RM6.49) Results Review Integrating Newly Acquired Assets Actual vs. expectation.
More informationYTL Corporation Berhad Taking YTLE private
26 July 2016 Corporate Update YTL Corporation Berhad Taking YTLE private Maintain NEUTRAL Maintain Target Price (TP): RM1.50 INVESTMENT HIGHLIGHT YTL is proposing to take 74% owned YTLE private To be satisfied
More informationMMC Corporation Berhad Recovery continues in ports segment
23 November 2017 3QFY17 Results Review MMC Corporation Berhad Recovery continues in ports segment INVESTMENT HIGHLIGHTS 9MFY17 earnings above estimates PTP and Johor Port continues to recover Malakoff
More informationMaintain BUY Revised Target Price (TP): RM8.72 (previously RM8.18)
21 February 2018 4QFY17 Results Review Petronas Chemicals Group Berhad Strong earnings delivered as expected INVESTMENT HIGHLIGHTS Petronas Chemicals Group Bhd s (PChem) 4QFY17 earnings expanded by +1.8%yoy
More informationDeleum Berhad. Maintain BUY Revised Target Price (TP): RM1.18 (previously RM1.25) Earnings visibility intact
28 February 2017 4QFY16 Results Review Deleum Berhad Earnings visibility intact INVESTMENT HIGHLIGHTS Deleum Berhad s (Deleum) 4QFY16 reported earnings rose two folds quarter-over-quarter to RM9.9m Margin
More informationTenaga Nasional Bonus earnings not sustainable
29 January 2018 1QFY18 Results Review Tenaga Nasional Bonus earnings not sustainable 1QFY18 within estimates RP1 earnings inflated by favourable customer mix Bonus regulated earnings not sustainable in
More informationIHH Healthcare IHH MK Sector: Healthcare & Pharmaceuticals
Inpatient admissions accelerated in 1Q16 Core net profit grew by a tepid 5% yoy in 1Q16, but we deemed this in-line with expectations. Revenue and EBITDA grew by 24% yoy and 17% yoy in the quarter, driven
More informationBermaz Auto Implications of Mazda s supply chain transplant
21 November 2016 Corporate Update Bermaz Auto Implications of Mazda s supply chain transplant INVESTMENT THESIS APM-Delta JV reflects Mazda s move to transplant its supply chain and transform its Malaysian
More informationTenaga Nasional Berhad Solid finish
28 October 2016 4QFY16 Result Review Tenaga Nasional Berhad Solid finish Maintain BUY Unchanged (TP): RM16.80 Tenaga s 4QFY16 beat estimates Volumes remained steady but average tariffs lower Our forecasts
More informationMaintain Buy. MISC Berhad
6 November 2017 3QFY17 Results Review MISC Berhad Pickup in the third quarter INVESTMENT HIGHLIGHTS 9MFY17 earnings above expectations LNG PBT improved with new-builds coming on stream Losses recorded
More informationYTL Corporation Berhad Implications from Brexit
28 June 2016 Corporate Update YTL Corporation Berhad Implications from Brexit Maintain NEUTRAL Maintain Target Price (TP): RM1.50 INVESTMENT HIGHLIGHT Weak GBP means translation losses for YTL Power Attains
More informationMaintain NEUTRAL. MISC Berhad
15 May 2018 1QFY18 Results Review MISC Berhad Petroleum segment remains challenging INVESTMENT HIGHLIGHTS 1QFY18 earnings below estimates Long term contracts to sustain LNG segment Petroleum segment to
More informationAirAsia X Berhad. Maintain BUY. Showing its mettle
22 February 2018 4QFY17 Results Review AirAsia X Berhad Showing its mettle Maintain BUY Adjusted Target Price(TP): RM0.46 (from: RM0.43) INVESTMENT HIGHLIGHTS AAX earned commendable net profit of RM98.9m
More informationBIMB Holdings Berhad Sturdy quarter backed by growth in banking and takaful segments
28 November 2013 3QFY13 Results Update BIMB Holdings Berhad Sturdy quarter backed by growth in banking and takaful segments Maintain NEUTRAL Target Price (TP): RM4.40 INVESTMENT HIGHLIGHTS BHB scored with
More informationHong Leong Bank Berhad Surprised provisions but better to be prudent
25 August 2017 4QFY17 Results Review Hong Leong Bank Berhad Surprised provisions but better to be prudent Revert to NEUTRAL Unchanged Target Price (TP): RM15.70 INVESTMENT HIGHLIGHTS FY17 was slightly
More informationKossan Rubber Industries Berhad Higher dividend in the horizon
09 November 2012 Visit Note Kossan Rubber Industries Berhad Higher dividend in the horizon HIGHLIGHTS New plant focusing on surgical gloves production expected to commence operation in December 2012. Product
More informationTenaga Nasional Maiden surcharge pass-through for 2H18
02 July 2018 Corporate Update Tenaga Nasional Maiden surcharge pass-through for 2H18 Maintain BUY Unchanged Target Price: RM16.30 ICPT pass-through for non-residential consumers Decision for narrower scope
More informationAMMB Holdings Berhad. Maintain NEUTRAL Revised Target Price (TP): RM5.55 (from RM4.55)
01 June 2017 4QFY17 Results Review AMMB Holdings Berhad Earnings growth due to NOII Maintain NEUTRAL Revised Target Price (TP): RM5.55 (from RM4.55) INVESTMENT HIGHLIGHTS FY17 earnings were within expectations
More informationWCT Holdings Berhad KINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES. Reaffirm BUY Unchanged Target Price (TP): RM2.
21 October 2014 Corporate Update WCT Holdings Berhad Acquiring another piece of land in Bandar Serendah Reaffirm BUY Unchanged Target Price (TP): RM2.59 INVESTMENT HIGHLIGHTS Acquiring 220.74 acres of
More informationCIMB Group Holdings Bhd
01 March 2018 4QFY17 Results Review CIMB Group Holdings Bhd Stellar ending INVESTMENT HIGHLIGHTS Exceeded our expectations, with strong NII and NOII growth, while cost contained NIM dipped in 3QFY17 due
More informationIOI Properties Group Berhad Ended FY18 on a weaker note
28 August 2018 4QFY18 Results Review IOI Properties Group Berhad Ended FY18 on a weaker note Maintain NEUTRAL Unchanged Target Price (TP): RM1.69 INVESTMENT HIGHLIGHTS FY18 earnings within our expectation
More informationPetronas Chemicals Group Berhad
22 May 2018 1QFY18 Results Review Petronas Chemicals Group Berhad Strong PUR and sales volume growth INVESTMENT HIGHLIGHTS Petronas Chemicals Group Bhd s (PChem) 1QFY18 earnings expanded by +6%qoq to RM1.1b
More informationIOI Properties Group Berhad Earnings on track
23 November 2016 1QFY17 Results Review IOI Properties Group Berhad Earnings on track Maintain NEUTRAL Unchanged Target Price (TP): RM2.34 INVESTMENT HIGHLIGHTS Earnings within expectations Growing earnings
More informationNew Hoong Fatt Holdings Berhad One-stop automotive replacement parts seller
05 April 2017 Small Cap Highlight New Hoong Fatt Holdings Berhad One-stop automotive replacement parts seller INVESTMENT HIGHLIGHTS Auto parts trader and maker with a good track record Strategic venture
More informationAirAsia Bhd Expect brighter prospects ahead
20 November 2014 3QFY14 Results Review AirAsia Bhd Expect brighter prospects ahead Maintain BUY Unchanged Target Price (TP): RM2.94 INVESTMENT HIGHLIGHTS Results slightly below expectations but we expect
More informationCIMB Group Holdings Bhd
31 October 2016 CIMB Niaga 3QFY16 Results Review CIMB Group Holdings Bhd Prospect brightening up in Indonesia Maintain BUY Unchanged Target Price (TP): RM5.50 INVESTMENT HIGHLIGHTS Strong quarter for CIMB
More informationIOI Properties Group Berhad Successfully tendered for land in Singapore
14 November 2016 Corporate Update IOI Properties Group Berhad Successfully tendered for land in Singapore Maintain NEUTRAL Unchanged Target Price (TP): RM2.65 INVESTMENT HIGHLIGHTS Successfully tendered
More informationMalaysia Resources Corporation Bhd
24 February 2015 4QFY14 Results Review Malaysia Resources Corporation Bhd Well positioned to regain its upward earnings trajectory Reaffirm BUY Adjusted Target Price (TP): RM2.24 (previously RM2.59) INVESTMENT
More informationKINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES
04 January 2016 Corporate Update Sunway Berhad Management sales target at RM1.4b for FY16 Maintain NEUTRAL Unchanged Target Price: RM3.20 INVESTMENT HIGHLIGHTS Management sales target at RM1.4b for FY16
More informationKPJ Healthcare Berhad Another hospital on deck
13 September 2012 Corporate Update KPJ Healthcare Berhad Another hospital on deck Maintain BUY Unchanged Target Price (TP): RM6.98 INVESTMENT HIGHLIGHTS Hospital acquired. KPJ s subsidiary, Ipoh Specialist
More informationUEM Sunrise Berhad New sales exceeded target in FY17
1 28 February 2018 4QFY17 Results Review UEM Sunrise Berhad New sales exceeded target in FY17 Maintain BUY Unchanged Target Price (TP): RM1.26 INVESTMENT HIGHLIGHTS FY17 earnings below expectation Higher
More informationBermaz Auto Strong comeback
13 March 2018 3QFY18 Result Review Bermaz Auto Strong comeback INVESTMENT THESIS 3Q18 results in-line Earnings gapped up 82%qoq and 61%yoy MMSB volumes/earnings hit record high Re-affirm BUY at unchanged
More informationBermaz Auto Darkest before dawn
14 June 2017 4QFY17 Results Review Bermaz Auto Darkest before dawn Maintain BUY Unchanged Target Price (TP):RM2.50 INVESTMENT THESIS 4QFY17 within our expectation, below consensus Impacted by weak RM but
More informationEastern & Oriental Berhad
16 November 2017 Briefing Note Eastern & Oriental Berhad Reclamations work of STP2A is progressing well Maintain BUY Unchanged Target Price (TP): RM2.37 INVESTMENT HIGHLIGHTS Improved earnings in 1HFY18
More informationUEM Sunrise Berhad JV with MULPHA to develop Nusajaya land
17 February 2016 Corporate Update UEM Sunrise Berhad JV with MULPHA to develop Nusajaya land Maintain NEUTRAL Unchanged Target Price (TP): RM1.11 INVESTMENT HIGHLIGHTS JV with MULPHA to develop Nusajaya
More informationUEM Sunrise Berhad Earnings boosted by land sales
1 21 November 2017 3QFY17 Results Review UEM Sunrise Berhad Earnings boosted by land sales Upgrade to BUY Unchanged Target Price (TP): RM1.24 INVESTMENT HIGHLIGHTS 9MFY17 earnings boosted by land sales
More informationRHB Capital Berhad Provisions likely to be higher moving forward
29 Feb 2016 4QFY15 Results Review RHB Capital Berhad Provisions likely to be higher moving forward INVESTMENT HIGHLIGHTS 12MFY15 normalised net profit of RM1.74b was below our expectation accounting for
More informationIOI Properties Group Berhad Proposes rights issue
21 November 2016 Corporate Update IOI Properties Group Berhad Proposes rights issue Maintain NEUTRAL Revised Target Price (TP): RM2.34 (Previously: RM2.65) INVESTMENT HIGHLIGHTS Proposes rights issue to
More informationSyarikat Takaful Malaysia Berhad Family Takaful leader
21 November 2013 Initiating Coverage Syarikat Takaful Malaysia Berhad Family Takaful leader BUY Target Price (TP): RM10.90 INVESTMENT HIGHLIGHTS Leader in the group Family Takaful business, with a 40%
More informationUEM Sunrise Berhad Disposal of Canada land for RM373m
1 14 March 2017 Corporate Update UEM Sunrise Berhad Disposal of Canada land for RM373m Maintain NEUTRAL Adjusted Target Price (TP): RM1.04 (Previously RM1.03) INVESTMENT HIGHLIGHTS Disposal of land in
More informationIHH Healthcare Berhad TP: RM6.65 (+10.8%) 1QFY17 Weighed by Pre-operating & Start-up Costs
A Member of the TA Group MENARA TA ONE, 22 JALAN P. RAMLEE, 50250 KUALA LUMPUR, MALAYSIA TEL: +603-20721277 / FAX: +603-20325048 RESULTS UPDATE Monday, May 22, 2017 FBM KLCI: 1,768.28 Sector: Healthcare
More informationV. S. Industry Berhad Non-rated Preparing for higher growth in 2HFY17
27 December 2016 1QFY17 Results Review and Visit Note V. S. Industry Berhad Non-rated Preparing for higher growth in 2HFY17 Fair Value (FV): RM1.42 INVESTMENT HIGHLIGHTS 1QFY17 results within expectations
More informationIOI Properties Group Berhad
26 February 2018 2QFY18 Results Review IOI Properties Group Berhad Earnings dragged by property development division INVESTMENT HIGHLIGHTS 1HFY18 earnings below expectations Earnings dragged by property
More informationEastern & Oriental Berhad Earnings improved
15 November 2017 2QFY18 Results Review Eastern & Oriental Berhad Earnings improved Maintain BUY Unchanged Target Price (TP): RM2.37 INVESTMENT HIGHLIGHTS 1HFY18 core net income within expectations Earnings
More informationUEM Sunrise Berhad. Maintain NEUTRAL. 1HFY17 earnings in line
1 24 August 2017 2QFY17 Results review UEM Sunrise Berhad 1HFY17 earnings in line Maintain NEUTRAL Unchanged Target Price (TP): RM1.24 INVESTMENT HIGHLIGHTS 1HFY17 earnings within expectation Sales of
More informationUEM Sunrise Berhad Strengthening presence in Klang Valley
1 16 April 2018 Corporate Update UEM Sunrise Berhad Strengthening presence in Klang Valley Maintain BUY Revised Target Price (TP): RM1.36 (Previously RM1.26) INVESTMENT HIGHLIGHTS Acquiring land in Kepong
More informationSignature International Berhad Cooking up better growth ahead
09 May 2017 Small Cap Highlight Signature International Berhad Cooking up better growth ahead INVESTMENT HIGHLIGHTS Orderbook of RM220m Facility expansion to cater for more value-added products Tapping
More informationSupermax Corporation Berhad Super value on offer
PP 10745/05/2013/032438 19 July 2012 Initiating coverage Supermax Corporation Berhad Super value on offer BUY Target Price (TP): RM2.48 INVESTMENT HIGHLIGHTS World class latex glove producer. SUPERMAX
More informationGamuda Bhd Stellar quarter, construction margin peaked
KDN: PP 10744/05/2013 29 June 2012 3QFY12 Results Review Gamuda Bhd Stellar quarter, construction margin peaked Maintain BUY Revised Target Price (TP): RM4.27 (from RM4.40 previously) INVESTMENT HIGHLIGHTS
More informationIHH Healthcare reports Q profit of RM57.2 million
IHH Healthcare reports Q1 2018 profit of RM57.2 million Q1 HIGHLIGHTS: Sustained organic growth YoY: Higher revenue; EBITDA up on improved operational performance - Q1 2018 revenue up 6% year-on-year to
More informationGabungan AQRS Berhad Flurry of Projects Could Improve Operational Margin
11 January 2018 Corporate Update Gabungan AQRS Berhad Flurry of Projects Could Improve Operational Margin INVESTMENT HIGHLIGHTS News influx injected fresh interest Beneficiary of buoyant activities in
More informationMaintain NEUTRAL. Mah Sing Group Berhad KINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES
18 May 2017 Corporate Update Mah Sing Group Berhad Acquiring Titiwangsa Land for RM60m INVESTMENT HIGHLIGHTS Acquiring Titiwangsa land for RM60m Valuation is fair in our view Positive on the news Earnings
More informationReach Energy Berhad Reaching a tipping point
08 August 2016 Corporate Update Reach Energy Berhad Reaching a tipping point Trading Idea Fair Value (FV): RM0.98 INVESTMENT HIGHLIGHTS Compelling valuation of assets Further potential upside from prospects
More informationUOA Development Berhad
KDN: PP 10744/06/2012 06 January 2012 Initiating Coverage UOA Development Berhad Thriving on fast track business model INVESTMENT HIGHLIGHTS Successful niche market developers: UOA Development Berhad (UOA)
More informationNotion VTec Berhad Brighter days ahead
13 February 2017 Small Cap Highlight Notion VTec Berhad Brighter days ahead INVESTMENT HIGHLIGHTS Set for a rebound Higher gear in the automotive segment Stronger balance sheet allows it to expand capacity
More informationEco World Development Group Berhad
10 June 2016 Corporate Update Eco World Development Group Berhad Landbanking at Bukit Raja, Klang Maintain BUY Adjusted Target Price (TP): RM1.68 (Previously RM1.62) INVESTMENT HIGHLIGHTS Acquiring 50%
More informationFOR IMMEDIATE RELEASE 23 August IHH Healthcare Reports Higher Net Profit at RM316.6 million for Q2 2017
IHH Healthcare Reports Higher Net Profit at RM316.6 million for Q2 2017 Q2 2017 revenue grew 12% to RM2.8 billion on sustained organic growth in all home markets and contribution from new hospitals Headline
More informationMaintain NEUTRAL. Mah Sing Group Berhad KINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES
14 September 2015 Corporate Update Mah Sing Group Berhad Strong balance sheet to weather challenges in the sector INVESTMENT HIGHLIGHTS RM1.06b sales for 7MFY15. Healthy balance sheet with net cash position.
More informationSupermax Corporation Berhad OBM expenses pressuring on profit margin
06 November 2015 Initiate Coverage Supermax Corporation Berhad OBM expenses pressuring on profit margin Initiate with NEUTRAL Target Price (TP): RM2.09 INVESTMENT HIGHLIGHTS Pioneer of OBM gloves in Malaysia
More informationIHH Reports Higher PATMI in Q on Asset Divestment amid Higher Costs
IHH Reports Higher PATMI in Q2 2016 on Asset Divestment amid Higher Costs Q2 2016 revenue up 18% YoY to RM2.5 billion; EBITDA up modest 2% YoY to RM554.4 million due to start-up costs from the new hospitals
More informationIHH Delivers Strong Growth in Q3 2016
IHH Delivers Strong Growth in Q3 2016 Double-digit revenue, EBITDA and headline PATMI growth of 18%, 15% and 46% to RM2.4 billion, RM546.3 million and RM173.3 million respectively Performance driven by
More informationMaintain BUY. SP Setia Berhad KINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES. Setia Eco Templer achieved 95% take up rate
03 June 2016 Corporate Update SP Setia Berhad Setia Eco Templer achieved 95% take up rate Maintain BUY Unchanged Target Price: RM3.70 INVESTMENT HIGHLIGHTS Setia Eco Templer in Rawang has achieved excellent
More informationM&A Research. Company Visit. M&A Securities. KPJ Healthcare Bhd. Prepared For Next Phase of Growth. Tuesday, June 28, 2016 HOLD (TP: RM4.
M&A Research M&A Securities Company Visit PP14767/09/2012(030761) Tuesday, June 28, 2016 KPJ Healthcare Bhd HOLD (TP: RM4.27) Prepared For Next Phase of Growth We made a visit to KPJ Healthcare Berhad
More informationEco World International Global Property Player
20 March 2017 IPO Note Eco World International Global Property Player Non Rated Fair Value: RM1.30 INVESTMENT HIGHLIGHTS Solid sales of RM6.49b due to strong management team Strategic location and innovative
More informationIHH Investor Presentation May 2014
IHH Investor Presentation May 2014 General Overview Quick Facts World s second-largest private healthcare provider by market cap IHH Healthcare Berhad (IHH) is a leading international provider of healthcare
More informationFOR IMMEDIATE RELEASE 27 November IHH Healthcare Reports RM82.1 million Net Profit for Q3 2017
IHH Healthcare Reports RM82.1 million Net Profit for Q3 2017 Q3 2017 revenue grew 15% to RM2.8 billion on sustained organic growth from existing operations and solid contribution from new hospitals Solid
More informationMarket Access. M&A Securities. Briefing Note. Cahya Mata Sarawak Berhad. Stop Bleeding, Keep Going BUY (TP: RM4.66)
M&A Securities Briefing Note PP14767/09/2012(030761) Cahya Mata Sarawak Berhad Wednesday, Sept 7, 2016 BUY (TP: RM4.66) Stop Bleeding, Keep Going We attended analyst briefing session of Cahya Mata Sarawak
More informationMarket Access. M&A Securities. Result Review (2Q16) Cahya Mata Sarawak Berhad. Good Recovery Seen BUY (TP: RM4.66) Result Review
M&A Securities Result Review (2Q16) PP14767/09/2012(030761) Cahya Mata Sarawak Berhad Thursday, Sept 1, 2016 BUY (TP: RM4.66) Good Recovery Seen Result Review Actual vs. expectation. Cahya Mata Sarawak
More informationMSM Malaysia Holdings Berhad
Important note and notice disclaimer: This report is strictly for LOCAL distribution only. KDN: PP 10744/06/2011 08 June 2011 IPO Listing Notes MSM Malaysia Holdings Berhad Sweet Rebirth Not Rated Target
More informationMarket Access. Results Review 4Q15. M&A Securities. Digi.Com Berhad. Survives the Headwinds BUY (TP:RM5.90) Results Review
M&A Securities Results Review 4Q15 PP14767/09/2012(030761) Digi.Com Berhad BUY (TP:RM5.90) Wednesday, February 10, 2016 Results Review Survives the Headwinds Current Price (RM) New Fair Value (RM) Previous
More informationMalaysia Bulk Carriers Banking on a recovery in dry bulk shipping
30 June 2016 Dry Bulk Shipping Update Malaysia Bulk Carriers Banking on a recovery in dry bulk shipping Maintain BUY Unchanged Target Price (TP): RM1.04 INVESTMENT HIGHLIGHTS BDI has improved to 640 since
More informationKINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES
27 December 2017 Sector Update Power Sector Maintain POSITIVE Overhang removed INVESTMENT HIGHLIGHTS Base tariff maintained for RP2 (2018-2020) - allowable returns unlikely to have significantly changed
More informationIHH Healthcare (LHS) Singapore Company Guide
Singapore Company Guide Version 2 Bloomberg: IHH SP Reuters: IHH.SI Refer to important disclosures at the end of this report DBS Group Research. Equity 26 Feb 2016 HOLD Last Traded Price: RM6.53/ S$2.10
More informationMarket Access. Results Review (2Q15) M&A Securities. Genting Plantations Berhad. Hit by Plantation-Malaysia Segment. Wednesday, August 26, 2015
M&A Securities Results Review (2Q15) PP14767/09/2012(030761) Genting Plantations Berhad Wednesday, August 26, 2015 HOLD (TP: RM9.66) Hit by Plantation-Malaysia Segment Results Review Actual vs. expectations.
More informationPPI Contracted for Two Consecutive Months as Prices Fell Further For Agriculture
30 March 2018 ECONOMIC REVIEW February 2018 Producer Price Index Contracted for Two Consecutive Months as Prices Fell Further For Agriculture Producer prices continued to fall for two consecutive months.
More informationMarket Access. Briefing Notes. M&A Securities. BIMB Holdings Bhd BUY (TP:RM4.60) Shifting into High Gears
M&A Securities Briefing Notes PP14767/09/2012(030761) BIMB Holdings Bhd BUY (TP:RM4.60) Monday, October 12, 2015 Shifting into High Gears We attended post-1h15 results briefing organized by BIMB Holdings
More informationMarket Access. Results Review 1Q16. M&A Securities. Digi.Com Berhad. Equipped for Competition BUY (TP:RM5.75) Results Review
M&A Securities Results Review 1Q16 PP14767/09/2012(030761) Digi.Com Berhad BUY (TP:RM5.75) Monday, April 25, 2016 Equipped for Competition Results Review Actual vs. expectations. Digi.Com (Digi) started
More informationNew Silk Road Beneficiary INVESTMENT HIGHLIGHTS
28 January 2016 Smallcap Highlight Vivocom International Holdings Berhad New Silk Road Beneficiary INVESTMENT HIGHLIGHTS Non-Rated Fair Value (FV): RM0.59 Vivocom International Holdings Berhad (VIHB) is
More informationResults Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013
Results Review (Member of Alliance Bank group) PP7766/03/2013 (032116) 8 November 2013 Analyst Toh Woo Kim wookim@alliancefg.com +603 2604 3917 12-month upside potential Previous target price 0.89 Revised
More information3Q18 Current Account Surplus Lowest Since 3Q16 amid Continued Deficit in Services
n ECONOMIC REPORT Balance of Payment 21 November 218 3Q18 Current Account Surplus Lowest Since 3Q16 amid Continued Deficit in Services Malaysia s current account surplus at 9-quarter low. Current account
More informationMarket Access. M&A Securities. Result Review (3Q16) Cahya Mata Sarawak Berhad. Loss-Making Business Turns Into Black BUY (TP: RM4.
M&A Securities Result Review (3Q16) PP14767/09/2012(030761) Cahya Mata Sarawak Berhad Thursday, Dec 1, 2016 BUY (TP: RM4.66) Loss-Making Business Turns Into Black Result Review Actual vs. expectation.
More informationMarket Access. M&A Securities. Results Review 1Q15. Malayan Banking Bhd BUY (TP: RM10.70) Stabilizing Period. Results Review
M&A Securities Results Review 1Q15 PP14767/09/2012(030761) Malayan Banking Bhd BUY (TP: RM10.70) Friday, May 29, 2015 Stabilizing Period Results Review Actual vs. expectation. Malayan Banking Berhad (Maybank)
More informationPPI Inched Up 0.1% in Jun-18 Driven By Rising Commodity Price
31 July 2018 ECONOMIC REVIEW June 2018 Producer Price Index Inched Up 0.1% in Jun-18 Driven By Rising Commodity Price grew for the first time in 2018. Malaysia s producer prices increased by 0.1%yoy in
More informationImproved Macroeconomic Conditions Boost Consumer Sentiment to Its Highest Level in 3½-Year
ECONOMIC REPORT Business & Consumer Confidence 17 April 2018 Improved Macroeconomic Conditions Boost Consumer Sentiment to Its Highest Level in 3½-Year MIER s CSI rebounded to 3.5-year high. Underpin by
More informationMarket Access. Company Update. M&A Securities. UMW Oil and Gas Corporation Bhd. Awards for NAGA 7 SELL (TP: RM0.90)
M&A Securities Company Update PP14767/9/212(3761) Friday, October 3, 215 UMW Oil and Gas Corporation Bhd Awards for NAGA 7 SELL (TP: RM.9) Current Price (RM) New Target Price (RM) Previous Target Price
More informationMarket Access. Results Review (4Q14) M&A Securities. Genting Plantations Berhad. Hit by Plantation-Malaysia Segment. Thursday, May 28, 2015
M&A Securities Results Review (4Q14) PP14767/09/2012(030761) Genting Plantations Berhad Thursday, May 28, 2015 HOLD (TP: RM10.77) Hit by Plantation-Malaysia Segment Results Review Actual vs. expectations.
More informationLBS Bina Group Transformed developer
12 November 2012 Small-cap highlights LBS Bina Group Transformed developer Target Price: RM1.02 Not rated INVESTMENT HIGHLIGHTS Transformed entity, more high-margin products (medium-high end residential)
More information